Related Experiment Video
Updated: Jun 26, 2026

11:21
Robotic Ablation of Atrial Fibrillation
Published on: May 29, 2015
The German Competence Network on Atrial Fibrillation (AFNET)
Günter Breithardt1, Dobromir Dobrev, Nicolas Doll
1Department of Medicine C - Cardiology and Angiology, University Hospital, Münster, Germany. g.breithardt@uni-muenster.de
Herz
|January 13, 2009
Summary
The German Competence Network on Atrial Fibrillation (AFNET) improves atrial fibrillation (AF) treatment through a national registry and clinical trials. Research identifies comorbidities and optimizes therapies, including anticoagulation and novel interventions for this common heart arrhythmia.
Area of Science:
- Cardiology
- Clinical Research
- Translational Science
Background:
- Atrial fibrillation (AF) is the most common sustained heart arrhythmia.
- The German Competence Network on Atrial Fibrillation (AFNET) was established to improve AF diagnosis and treatment.
- Patients with AF often present with advanced age and multiple comorbidities.
Purpose of the Study:
- To improve the treatment and management of atrial fibrillation.
- To establish a nationwide patient registry for AF manifestation, diagnostics, and therapy.
- To conduct clinical trials for optimizing pharmacological and non-pharmacological AF treatments.
Main Methods:
- Established a nationwide patient registry in Germany.
- Conducted basic research on AF-induced atrial tissue remodeling.
- Initiated clinical trials including ANTIPAF, Flec-SL, Gap-AF, and BACE-PACE.
Main Results:
- Data indicate high guideline adherence for oral anticoagulation in AF patients.
- Basic research identified therapeutic targets in AF-induced atrial remodeling.
- Clinical trials are investigating novel interventions like angiotensin II receptor blockers and optimized ablation techniques.
Conclusions:
- AFNET plays a crucial role in advancing the understanding and treatment of atrial fibrillation.
- Ongoing research and trials aim to reduce AF recurrence and improve patient outcomes.
- Optimizing anticoagulation and exploring new therapeutic strategies are key focuses.

